Asserting the Autoimmune Need for Genetic Intervention (Apr 20, 2022)
It is understandable that public opinion regarding gene editing technology such as CRISPR remains generally wary and distrustful. Not only does CRISPR’s relative novelty compared to established medical treatments impact public perceptions of its safety and effectiveness, but controversies surrounding its limitations and ethical uses further fuel negative responses. While these fears can be healthy and reasonable, it is unreasonable that they should completely impede beneficial medical advancements – nor should those fears attempt to assert that current approaches to medical treatment cannot be improved upon when studies show the opposite. Research into autoimmune diseases such as Hashimoto’s disease not only support the necessity for treatment reform, but also reveal that CRISPR shows promising potential to become a groundbreaking treatment for various autoimmune diseases. More forward thinking, CRISPR could one day have the power to remove the hereditar...